Pharmacy Disclosure Log 2025
- Asthma Response 1003
- Asthma Response 1003 Attachment
- Atopic Dermatitis Response 981
- Biologics Rheumatology Response 1057
- Biologics - Dermatology Response 1046
- Biologic Medicines in Gastroenterology Response 847
- Biologics Gastro Response 1128
- Biologics Rheumatology Response 762
- Blood Cultures Response 940
- Bruxism Data Response 1134
- Curosurf and Peyona Response 1110
- Dermatology and Respiratory Medicine Response 977
- Dermatology Response 771
- Diffuse Large B Cell Lymphoma Response 827
- Endometrial Cancer Response 923
- Eosinophilic Oesophagitis (EoE) Response 972
- Elastomeric Infusion Devices Response 1031
- Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and Blood Products Response 772
- Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and blood Products Response 772 Attachment
- Formularies and Committees Response 941
- Friedreich Ataxia Response 921
- Gastroenterology Response 1156
- Giant Cell Arteritis Response 1083
- Human Albumin Response 826
- Immunoglobulin Treatment Response 932
- Intra-Vitreal Injections Implants Response 810
- Intra-vitreal treatments Response 870
- Intra-Vitreal Injections or Implants Response 1066
- Intra-Vitreal Treatments Response 1145
- Lung Cancer Response 1148
- Lung Cancer Response 864
- Lung Cancer Response 864 Attachment
- Medication errors Rocuronium Response 918
- Melanoma Response 901
- Migraine Response 856
- Migraine Response 1138
- Multiple Myeloma Response 1015
- Multiple Sclerosis Response 1079
- Multiple Sclerosis Response 1079 - Attachment
- New Biologic and Targeted Medications Response 867
- Non-Medical uses of Blood Response 802
- NHS Pharmacy Aseptic Services Response 803
- Oncology Breast Cancer Response 1118
- Oncology Response 1146
- Oncology Breast Cancer Response 857
- Oncology Response 928
- Orthopaedic Antibiotic Guidelines for Open Fractures, Closed Trauma, and Elective Surgery Response 1155
- Orthopaedic Antibiotic Guidelines for Open Fractures, Closed Trauma, and Elective Surgery Response 1155 - Attachment
- Ovarian Cancer Response 944
- Pancreatic Enzyme Replacement Therapy (PERT) Response 1114
- Patients treated with Ruxolitinib Response 933
- Patients treated with Ruxolitinib Response 933 Attachment
- Prescription CBPMs Response 998
- Prescription CBPMs Response 998 - Attachment
- Primary Diagnosis of GCA Response 784
- Prostate Cancer Patient Response 984
- Renal Cell Carcinoma Response 871
- Renal Cell Carcinoma Response 871 Attachment
- Social Prescribing Response 1021
- Sodium Chloride and Levofloxacin in Ophthalmology Response 994
- Spinal Muscular Atrophy Response 794
- Spinal Muscular Atrophy Response 1078
- Spinal Muscular Atrophy Response 1078 - Attachment
- Treatment of Insomnia Response 1109
- Treatment of Breast Cancer Response 1112
- Treatment of Breast Cancer Response 1112 - Attachment
- Trust Processes to Reduce Medication Waste Response 885
- Urothelial Cancer Response 930
- Wound Formulary Response 860
Last Modified: 11:30am 08/07/2025